search icon
  • Print
  • ShareThis
  • Text Size
  • Society Citation Award Winners 


    Current Winners

    DavidDAVID L. THOMAS, MD, MPH, FIDSA, for his pivotal work in leading IDSA’s Hepatitis Task Force, including the effort to develop new guidance for the treatment of hepatitis C virus (HCV) infection, is the recipient of IDSA’s 2014 Society Citation. First awarded in 1977, this is a discretionary award given in recognition of exemplary contribution to IDSA, an outstanding discovery in the field of infectious diseases (ID), or a lifetime of outstanding achievement.

    Since its first meeting in 2012, the IDSA Hepatitis Task Force led by Dr. Thomas has made remarkably swift progress in bringing viral hepatitis to the forefront of the practice of infectious diseases, launching a living, online document (HCVguidelines.org) that brings the expert guidance of leaders in the field to the care of HCV disease, and initiating a broad range of sustainable educational activities for IDSA members. In combination with his keen foresight recognizing the importance of HCV and its treatment to the future efforts of the ID clinician, Dr. Thomas’s energy, focus, and determination have been critical to the task force’s success.

    The Stanhope Bayne Jones Professor of Medicine in the Johns Hopkins University School of Medicine and a professor in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health, he is chief of the Division of Infectious Diseases at the School of Medicine and a leader in the field of viral hepatitis, and in particular, HCV disease.

    Dr. Thomas led and organized the efforts of a joint panel of specialists representing IDSA and the American Association for the Study of Liver Diseases (AASLD) to develop timely, evidence-based, consensus recommendations for the screening, treatment, and management of HCV, in light of new direct-acting agents with the potential to cure HCV infection. The new guidance, also developed in collaboration with the International Antiviral Society-USA (IAS-USA), was released in January 2014, within four months of the initial U.S. approval of the first new generation, directly acting HCV drug. A dramatic step forward in the current information available to clinicians and patients, the guidance will be updated and expanded in real time to keep pace with improved diagnostic tools and new drug options as they are approved.

    Recognizing how critical the education of the ID clinician will be in addressing the needs of HCV-infected patients, Dr. Thomas led the Hepatitis Task Force’s efforts in obtaining a three-year grant from the Agency for Healthcare Research and Quality to support the development of educational programs. These include monthly webinars, a web-based HCV Maintenance of Certification module, an online core curriculum providing foundational knowledge points for treating HCV, and IDWeek programming, which will be sustained within ongoing IDSA activities.

    Under the leadership of Dr. Thomas, IDSA’s Hepatitis Task Force successfully advocated for the United States Preventive Services Task Force to strengthen its recommendation that all Americans born between 1945 and 1965 be screened once for hepatitis C. The stronger recommendation for birth cohort screening, issued in 2013, will influence not only medical practice, but also coverage decisions by private and public insurers, with the potential to identify an estimated 800,000 baby boomers who do not know they are infected and link them to care.

    An IDSA John F. Enders Lecturer in 2012, he has been an invited speaker at leading scientific meetings and a consultant to the Centers for Disease Control and Prevention, the National Institutes of Health, and the state of Maryland, on viral hepatitis. He completed an internship, residency, and chief residency at Wake Forest University School of Medicine, and a fellowship in infectious diseases at the Johns Hopkins University School of Medicine, after earning his medical degree from West Virginia University School of Medicine in 1986. He received a master of public health degree from the Johns Hopkins University Bloomberg School of Public Health in 1992 and joined the faculty at the Johns Hopkins University School of Medicine in 1993.

    For his strong and effective leadership of IDSA’s Hepatitis Task Force, which in a short time has made substantial contributions to the rapidly evolving field of viral hepatitis treatment, IDSA is honored to recognize Dr. Thomas with the 2014 Society Citation.


    Past Society Citation Award Winners

    2013 Marguerite A. Neill, MD
    Catherine M. Wilfert, MD
    2012 Myron S. Cohen, MD, FIDSA
    N. Cary Engleberg, MD, FIDSA
    Alan D. Tice, MD, FIDSA, FSHEA 
    2011

    Carol J. Baker, MD, FIDSA
    Wafaa El-Sadr, MD, MPH, MPA, FIDSA

    2010

    John G. Bartlett, MD, FIDSA
    Theodore C. Eickhoff, MD, FIDSA

    2009 Warren D. Johnson, Jr., MD, FIDSA 
    2008 Russell Petrak, MD
    2007

    Gary P. Wormser, MD, FIDSA
    Eduardo Gotuzzo, MD, FIDSA

    2006

    Larry J. Strausbaugh, MD, FIDSA

    2005

    George G. Jackson, MD
    Lawrence P. Martinelli, MD

    2004

    Stanley Falkow, PhD
    Walter T. Hughes, Jr., MD
    Emanuel Wolinsky, MD

    2003 Morton N. Swartz, MD
    Julie Gerberding, MD, on behalf of the CDC staff
    2002 Marvin Turck, MD
    C. Douglas Webb, PhD
    2001 George W. Counts, MD
    2000 Dennis George Maki, MD
    Dennis L. Stevens, MD, PhD
    1999 Sydney Finegold, MD
    1998 Porter Anderson, PhD
    John Robbins, MD
    Rachel Schneerson, MD
    David Smith, MD
    1997 Johan Septimus Bakken, MD
    1996 Donald A. Henderson, MD
    1995 King Holmes, MD, PhD
    1994 David Rogers, MD
    Edward Hook, III, MD
    1993 Dorothy Horstmann, MD
    Samuel Katz, MD
    Harold Neu, MD
    1992 Robert Austrian, MD
    Jay Sanford, MD
    1988 Martha Yow, MD
    1987 Margaret Pittman, PhD, MS
    1986 Victor Nussenzweig, MD
    1985 Robert Gallo, MD
    Luc Montagnier, CNRS
    Sheldon Wolff, MD
    1984 Allen Steere, MD
    1983 Maurice Hilleman, PhD
    Saul Krugman, MD
    1982 James Todd, MD
    1981 Don Brenner, MS, PhD
    William Cherry MS, PhD and Colleagues
    James Freeley, PhD
    Joseph McDade, PhD
    1977 Edward Kass, MD, PhD, M

     

 

| HIVMA | Contact Us

© Copyright IDSA 2014 Infectious Diseases Society of America

Full Site Mobile Site